Sol-Gel Technologies Ltd. (SLGL)
The price, the headline numbers and the latest news, in one place.
Sol-Gel Technologies Ltd. (SLGL) Stock Price, Analysis & Data
| Bid | 79.86 |
| Market Cap | 263.12M |
| Revenue (ttm) | 1.79M |
| Net Income (ttm) | -16.34M |
| 1.16 | |
| -5.62 | |
| n/a | |
| -10.45 | |
| P/B (ttm) | 5.48 |
| P/S (ttm) | 145.52 |
| Earnings Date | May 1, 2026 |
| Ask | 82.5 |
| Volume | 30,241 |
| Avg. Volume (20D) | 44,988 |
| Open | 78.88 |
| Previous Close | 77.39 |
| Day's Range | 78.88 - 81.10 |
| 52-Week Range | 20.10 - 97.97 |
| Analyst | Strong Buy |
| Price Target | 195 (142.27%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SLGL
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It als...
Financial Performance
In 2025, Sol-Gel's revenue was 19.39M, an increase of 68.04% compared to the previous year's 11.54M. Earnings were -6.13M, a decrease of -42.09%.
Financial StatementsAnalyst Forecast
According to 3 analyst ratings, the average rating for SLGL stock is "Strong Buy". The 12-month stock price forecast is 195, which is upside of 142.27% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $108K misses estimates by $0, with -89.52% YoY decline.
- EPS of -1.13 exceeds estimates by 1.18, with -127.10% YoY decline.
Analysts project revenue of ... Upgrade
